Aviceda seeks $200M for AVD-104 trial, Nerviano reacquires NMS-293 from Merck KGaA, MaaT Pharma reports positive Phase 1b ALS drug data, Secretome raises $20.4M, 35Pharma secures $35M Series C, ...

The company’s oral, microbiome-changing therapy was well tolerated in patients with amyotrophic lateral sclerosis.

KIIT-DU ( has secured an impressive 4th position in India in the inaugural Times Higher Education (THE) Interdisciplinary Science Rankings 2025, which recognizes universities excelling in ...

MaaT Pharma Announces Positive Phase 1b Results, Meeting Primary Endpoint in the Evaluation of MaaT033 in Amyotrophic Lateral ...

Report on how AI is driving market transformation - The global microbiomes market size is estimated to grow by USD 1.13 ...

Schlafender Hase announced today the release of TVT 12, the latest version of its industry-trusted proofreading software. This upgrade features enhanced tools for efficiency and regulatory compliance, ...

An employee checks equipment at a pharmaceutical plant in Lianyungang, Jiangsu province. GENG YUHE/FOR CHINA DAILY BEIJING -- China has highlighted its commitment to encouraging the long-term ...

LATEST NEWS 19:10 Election today: Rival leaders pile pressure on Harris over John McGahon controversy 18:57 Analysis: Governments face dilemma as bond yields rise but spending pressures remain as ...

As Nigeria struggles over the high cost of essential drugs, Seagreen Pharmaceuticals has officially reintroduced the amino acid and multivitamin supplement, Amino Pep Forte. The unveiling held on ...

The Pharmaceutical Society of Nigeria has described the immediate past president of the organisation Pharmacist Prof. Cyril Odianose Usifoh as a transformational leader. Pharmacists disclosed this ...

Drugmaker Mayne Pharma Group, which has lost 59 per cent of its share market value over the past five years, is giving some thought to life away from the ASX boards. Pubs baron Bruce Mathieson at ...

Discount pharmacy retailer Chemist Warehouse will be allowed to merge with Sigma Healthcare to create an $8.8 billion pharmaceutical giant after being approved by Australia's competition regulator ...